Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Psiguavin, a Bioactive Compound Derived From Psidium Guava, as Therapeutic Agent for Obesity Treatment

NCT06512818 is registered in ClinicalTrials.gov with Universidad Católica San Antonio de Murcia as lead sponsor.

NCT NCT06512818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06512818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Psiguavin, a Bioactive Compound Derived From Psidium Guava, as Therapeutic Agent for Obesity Treatment
Lead sponsor
Universidad Católica San Antonio de Murcia
Phase
Phase 1/2
Overall status
Enrolling by invitation
Start date
January 8, 2025
Completion date
December 19, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight or obesity